Cure My Disease

Don't miss your cure!

 Log in / Sign up

New eye drop hopes to bring tears to dry eyes

NCT ID NCT07502378

Recruiting now Symptom relief Sponsor: University of South Florida Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a new eye drop called acoltremon can help people with a specific type of dry eye caused by early nerve damage (stage 1 neurotrophic keratopathy). The study will include 50 adults who have both decreased tear production and reduced corneal sensation. Researchers will measure tear production before and after using the drops over 8 weeks.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OCULAR SURFACE DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

neurotrophic keratopathy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NEUROTROPHIC KERATOPATHY STAGE 1 OCULAR SURFACE DISEASE

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of South Florida/Ophthalmology

    RECRUITING

    Tampa, Florida, 33612, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••